Select IV Solutions Recalled

On March 17, 2026, Fresenius Kabi USA, LLC initiated a voluntary user level recall of select lots of 0.9% Sodium Chloride Injection, USP, 0.45% Sodium Chloride Injection, USP, and 5% Dextrose Injection, USP supplied in single dose freeflex® bags. The recall was prompted by reports that a blue Break off Part (BOP) attached to the infusion port may detach during handling. A health hazard evaluation determined the risk to patients and healthcare professionals to be low, and no adverse events have been reported for the affected lots. These IV solutions are commonly used to support hydration, electrolyte balance and medication administration. Because they are delivered directly into the bloodstream, any defect affecting container or infusion port integrity could pose a potential risk of contamination, therapy interruption or administration difficulties if not promptly addressed. For more information, see here.